SIC
ATRC icon

SJS Investment Consulting’s AtriCure ATRC Stock Holding History

SJS Investment Consulting’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64K Buy
130
+119
+1,082% +$3.35K ﹤0.01% 1517
2026
Q1 		$314 Buy
+11
New +$375 ﹤0.01% 1882
2023
Q1 		– Sell
-4
Closed -$178 – 1584
2022
Q4 		$178 Buy
4
+2
+100% +$84 ﹤0.01% 1431
2022
Q3 		$0 Buy
+2
New +$91 ﹤0.01% 1042

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SJS Investment Consulting's ATRC Position: Q2 2026 in Review

SJS Investment Consulting increased its AtriCure (ATRC) stake by 1,082% in Q2 2026, buying an estimated $3.35K and bringing the position to 130 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

SJS Investment Consulting first reported a position in ATRC in Q3 2022 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • SJS Investment Consulting held 130 shares of AtriCure worth $3.64K as of Q2 2026.
  • SJS Investment Consulting bought 119 AtriCure shares in Q2 2026, an estimated $3.35K.
  • AtriCure made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1517 holding.
  • SJS Investment Consulting first reported a position in AtriCure in Q3 2022 and has held it in 4 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.